Table 3 Multivariate analysis model for predictors of mortality among hospitalized PLHIV at KNRH

Sex

 Female

1

1

 Male

1.20 (1.07–1.35)

0.002

1.13 (0.99–1.29)

0.064

Address

 Distance < 10 km from hospital

1

1

 Distance 10-20 km from hospital

1.08 (0.94–1.24)

0.253

0.99 (0.85–1.15)

0.889

 Distance > 20 km from hospital

1.32 (1.14–1.53)

< 0.001

1.23 (1.04–1.46)

0.014

Admission Status

 New

1

1

 Readmission

0.71 (0.58–0.87)

0.001

0.70 (0.56–0.88)

0.002

ART Status at Admission

 Active on ART

1

1

 ART Naïve

1.14 (0.97–1.34)

0.116

1.03 (0.85–1.23)

0.787

 ART Interruption

1.60 (1.38–1.85)

< 0.001

1.33 (1.13–1.57)

0.001

CD4 Documentation status

 CD4 + > 201 cells/µL

1

1

 CD4 + ≤ 200 cells/µL

1.88 (1.59–2.21)

< 0.001

1.59 (1.33–1.91)

< 0.001

 CD4 + Not Documented

1.96 (1.66–2.32)

< 0.001

2.08 (1.73–2.50)

< 0.001

Function Assessment

 ECOG Score 1–2

1

1

 ECOG Score 3–4

7.23 (6.34–8.24)

< 0.001

7.35 (6.42–8.41)

< 0.001

Clinical Diagnoses

 Liver disease

1.69 (1.35–2.13)

< 0.001

1.77 (1.36–2.30)

< 0.001

 COVID-19

1.96 (1.46–2.63)

< 0.001

1.70 (1.22–2.37)

0.002

 Co-infections

1.60 (1.40–1.82)

< 0.001

1.53 (1.32–1.78)

< 0.001

 Diabetes Mellitus

0.79 (0.61–1.01)

0.057

0.82 (0.62–1.08)

0.157

 Chronic lung disease

0.70 (0.48–1.01)

0.054

0.62 (0.41–0.92)

0.019

 Neurologic disorders

0.55 (0.39–0.78)

0.001

0.46 (0.32–0.68)

< 0.001